Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIL-2 in Children With Henoch-Schönlein Purpura
NCT04387942Completed
- Sponsor
- The First Hospital of Jilin University
- Start
- Jun 2020
- Primary completion
- May 2022
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Open-label trial of aldesleukin in immunoglobulin A vasculitis (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: The change of immunological responses at day 7. Started Jun 2020; status: completed.
02
Drugs
aldesleukin
03
Conditions
immunoglobulin A vasculitis
Beyond the preview
Go deeper on NCT04387942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04387942.